111
5
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T40286 | KRAS G12C inhibitor 19 | Ras | |
KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth. | |||
T6556 | K-Ras(G12C) inhibitor 9 | Raf | |
K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C). | |||
T3725 | K-Ras(G12C) Inhibitor 6 | Raf | |
K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro. | |||
T6555 | K-Ras(G12C) inhibitor 12 | Apoptosis , Raf , Ras | |
K-Ras(G12C) inhibitor 12 is an allosteric inhibitor of oncogenic K-Ras(G12C). | |||
T11738 | K-Ras G12C-IN-4 | Ras | |
K-Ras G12C-IN-4, is a potent Covalent Inhibitor of KRASG12C.. | |||
T40285 | KRAS G12C inhibitor 18 | ||
KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities. | |||
T77802 | KRAS G12C inhibitor 1R | ||
KRAS G12C inhibitor 1R can be used in studies about Ras. | |||
T11769 | KRAS G12C inhibitor 15 | Ras | |
KRAS G12C inhibitor 15 is a potent KRAS G12C inhibitor . | |||
T11768 | KRAS G12C inhibitor 14 | Ras | |
KRAS G12C inhibitor 14 is a potent KRAS G12C inhibitor with an IC 50 of 18 nM [1]. | |||
T11778 | KRas G12C inhibitor 3 | Ras | |
KRas G12C inhibitor 3 is a compound that inhibits KRas G12C. | |||
T11780 | KRAS G12C inhibitor 5 | Ras | |
T11767 | KRAS G12C inhibitor 13 | Ras | |
KRAS G12C inhibitor 13 is a KRAS G12C inhibitor . | |||
T11779 | KRas G12C inhibitor 4 | Ras | |
KRas G12C inhibitor 4 is a compound that inhibits KRas G12C. | |||
T11776 | KRas G12C inhibitor 1 | Ras | |
KRas G12C inhibitor 1 is a compound that inhibits KRas G12C. | |||
T11771 | KRAS G12C inhibitor 17 | Ras | |
KRAS G12C inhibitor 17 is a potent KRAS G12C inhibitor. | |||
T11770 | KRAS G12C inhibitor 16 | Ras | |
KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor. | |||
T11777 | KRas G12C inhibitor 2 | Ras | |
KRas G12C inhibitor 2 is a compound that inhibits KRas G12C. | |||
T11736 | K-Ras G12C-IN-2 | Others | |
K-Ras G12C-IN-2 is a covalent kras g12c inhibitor. | |||
T11735 | K-Ras G12C-IN-1 | Phosphatase | |
K-Ras G12C-IN-1 is a novel and irreversible inhibitor of mutant K-ras G12C. | |||
T11737 | K-Ras G12C-IN-3 | Others | |
Heterocyclic compounds as covalent inhibitors of G12C mutant K-Ras protein useful for treating cancers.K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C. | |||
T77805 | KRAS G12C mutant protein inhibitor A-1 | ||
KRAS G12C mutant protein inhibitor A-1 can be used in studies about Ras. | |||
T78651 | Glecirasib | JAB-21822,KRAS G12C inhibitor 36 | Ras |
Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor targeting the oncogenic KRAS G12C mutation, a key signaling molecule within the Ras protein family that is crucial for cell growth and development. This compound ... | |||
T63927 | KRAS G12C inhibitor 25 | ||
KRAS G12C inhibitor 25 is an inhibitor of KRAS G12C. KRAS G12C inhibitor 25 inhibits the SOS1-assisted GDP/GTP exchange activity of KRAS-G12C mutants with an IC50 value of 0.48 nM. | |||
T62566 | KRAS G12C inhibitor 53 | ||
KRAS G12C inhibitor 53 (Compound 1) is a KRAS G12C inhibitor. | |||
T64095 | KRAS G12C inhibitor 42 | ||
KRAS G12C inhibitor 42 is a potent inhibitor of KRAS G12C. KRAS G12C inhibitor 42 has shown potential for the investigation of KRAS G12C-mediated cancers. | |||
T63502 | KRAS G12C inhibitor 31 | ||
KRAS G12C inhibitor 31 is an inhibitor of KRAS G12C that can be used to study cancer. | |||
T72335 | KRAS G12C inhibitor 32 | Ras | |
KRAS G12C Inhibitor 32, an eight-membered heterocyclic compound with nitrogen, acts as a potent inhibitor of KRAS G12C [1]. | |||
T63863 | KRAS G12C inhibitor 47 | ||
KRAS G12C inhibitor 47 is a potent inhibitor of KRAS G12C (IC50: 0.172 μM). KRAS G12C inhibitor 47 exhibits p-ERK inhibition in MIA PaCA-2 cells, A549 cells with IC50 values of 0.046 μM and 69.8 μM respectively. KRAS G12... | |||
T64093 | KRAS G12C inhibitor 44 | ||
KRAS G12C inhibitor 44 is a potent, orally active KRAS G12C inhibitor. KRAS G12C inhibitor 44 exhibits anti-proliferative effects in MIA PaCA-2 (IC50: 0.016 μM), H358 cells (IC50: 0.028 μM). inhibitor 44 has anti-tumour ... | |||
T72344 | KRAS G12C inhibitor 41 | ||
KRAS G12C Inhibitor 41 is a potent agent targeting the KRAS G12C mutation within the Ras family of proteins, which are crucial for intracellular signaling related to growth and development. This compound holds significan... | |||
T72338 | KRAS G12C inhibitor 35 | ||
KRAS G12C Inhibitor 35 is a potent suppressor of KRAS G12C, targeting a crucial member of the Ras protein family which significantly impacts cellular growth and development. This compound holds promise for investigating ... | |||
T72346 | KRAS G12C inhibitor 20 | ||
KRAS G12C inhibitor 20 is a KRAS G12C inhibitor. | |||
T72336 | KRAS G12C inhibitor 45 | ||
KRAS G12C inhibitor 45 is a potent KRAS G12C inhibitor . | |||
T64142 | KRAS G12C inhibitor 46 | ||
KRAS G12C inhibitor 46 is a potent inhibitor of KRAS G12C. | |||
T63807 | KRAS G12C inhibitor 33 | ||
KRAS G12C inhibitor 33 is a KRAS G12C inhibitor that can be used to study cancer. | |||
T63501 | KRAS G12C inhibitor 30 | ||
KRAS G12C inhibitor 30 is an inhibitor of KRAS G12C and can be used to study cancer. | |||
T64033 | KRAS G12C inhibitor 34 | ||
KRAS G12C inhibitor 34 is an inhibitor of KRAS G12C that can be used to study cancer research. | |||
T72343 | KRAS G12C inhibitor 40 | ||
KRAS G12C inhibitor 40, a potent suppressor of the KRAS G12C, targets the Ras family of intracellular signaling proteins crucial for growth and development. This compound holds significant potential for researching cance... | |||
T72356 | KRAS G12C inhibitor 56 | ||
KRAS G12C inhibitor 56, a powerful inhibitor of SOS1 with an inhibitory concentration (IC50) of 1.6 nM, holds promise for use in cancer research. | |||
T63926 | KRAS G12C inhibitor 22 | ||
KRAS G12C inhibitor 22 is a KRAS G12C inhibitor. | |||
T64115 | KRAS G12C inhibitor 51 | ||
KRAS G12C inhibitor 51 is a KRAS G12C inhibitor. | |||
T64097 | KRAS G12C inhibitor 21 | ||
KRAS G12C inhibitor 21 is a KRAS G12C inhibitor. | |||
T63891 | KRAS G12C inhibitor 50 | ||
KRAS G12C inhibitor 50 is a KRAS G12C inhibitor (IC50: 46.7 nM). | |||
T72342 | KRAS G12C inhibitor 39 | ||
KRAS G12C Inhibitor 39, a potent antagonist, specifically targets the KRAS G12C mutation, a prime focus in pharmaceutical cancer research. This compound shows promise for investigating KRAS G12C-mediated cancer. | |||
T62785 | KRAS G12C inhibitor 29 | ||
KRAS G12C inhibitor 29 is an inhibitor of KRAS G12C and can be used to study cancer. | |||
T72347 | KRAS G12C inhibitor 24 | ||
KRAS G12C Inhibitor 24 is a potent inhibitor that effectively disrupts the interaction between KRAS G12C and SOS1, achieving an inhibitory concentration (IC 50) of less than 50 nM. | |||
T64039 | KRAS G12C inhibitor 49 | ||
KRAS G12C inhibitor 49 is an orally active KRAS G12C inhibitor that exhibits antitumour effects. | |||
T79057 | KRAS G12C inhibitor 58 | Ras | |
KRAS G12C inhibitor 58 is utilized in cancer research as an inhibitor of the KRAS G12C mutation [1]. | |||
T72340 | KRAS G12C inhibitor 37 | ||
KRAS G12C Inhibitor 37, a potent inhibitor of KRAS G12C, targets the Ras family of proteins, crucial for intracellular signaling related to growth and development. This compound holds potential for research into cancers ... | |||
T72334 | KRAS G12C inhibitor 28 | ||
KRAS G12C Inhibitor 28 is a compound that effectively inhibits the KRAS G12C mutation, exhibiting potent antitumor effects with an inhibitory concentration (IC50) of 57 nanomoles (nM). |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-04116 | KRAS Protein,Human,Recombinant(G12C & Q61H, His) | Human | E. coli |
KRAS Protein,Human,Recombinant(G12C & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2. | |||
TMPJ-00510 | KRAS Protein, Human, Recombinant (G12C, His) | Human | E. coli |
KRAS Protein, Human, Recombinant (G12C, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 26 KDa and the accession number is AAH13572.1. | |||
TMPK-01463 | HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... | |||
TMPK-01433 | HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... | |||
TMPK-01462 | HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... |